OTC · Financial Statements
ImpediMed Limited (IPDQF) Financial Statements
$0.00
OTC: IPDQF
Market Cap $6.91M
Overview Financials Dividend
ImpediMed Limited most recently reported annual revenue of $13.0M, a net loss of $23.0M. Revenue grew at an average annual rate of 16.7% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $8.0M $10.0M $11.0M $10.0M $13.0M Operating Profit $-23.0M $-22.0M $-23.0M $-24.0M $-24.0M Net Profit $-21.0M $-20.0M $-21.0M $-20.0M $-23.0M EPS $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 Op Margin -276.2% -205.2% -201.4% -241.8% -190.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $34.0M $59.0M $69.0M $47.0M $42.0M Total Liabilities $9.0M $8.0M $8.0M $6.0M $21.0M Cash $20.0M $41.0M $46.0M $25.0M $22.0M Borrowings $0 $0 $1.0M $1.0M $14.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-13.0M $-16.0M $-18.0M $-18.0M $-15.0M Investing Cash Flow $-7.0M $-16.0M $-18.0M $-6.0M $-2.0M Financing Cash Flow $-1.0M $-3.0M $-1.0M $-1.0M $-2.0M Net Cash Flow $0 $21.0M $5.0M $-21.0M $-2.0M Free Cash Flow $-16.0M $-21.0M $-24.0M $-21.0M $-16.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.03 EV / EBITDA -0.80 FCF Yield -84.96% Quick Ratio 3.41 Interest Coverage -7.45 Return 1Y -86.80% Return 3Y -97.46% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .